Fe/sub 79/Ta/sub 10/C/sub 11/
Sub-10 nm Cu<sub>5</sub>FeS<sub>4</sub> cube for magnetic resonance imaging-guided photothermal therapy of cancer
... ° C to 49 ° C and temperature of the PBS + laser group only increase from 33 ° C to ...° C (Figure ...° C obtained by the Cu 5 FeS 4 cube under the laser ...
10
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... characterization, Fe m O n -SiO 2 composite flake-like and SiO 2 -Fe m O n core-shell IONPs demonstrated spherical shape with mean diameter of 98 ± 22 and 101 ± 19 nm, respectively (Figure ...2B–E). ...
11
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... that Fe 3 O 4 @Au composite MNPs were almost ingested and deposited in the liver because no nanoparticles and hemosiderosis were observed in other organs including heart, spleen, lung, kidney, and brain, ...
15
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... DMP was suspended in 10 mL phosphate-buffered saline (PBS) solution, and incubated with 5 mg EDC and 5 mg NHS for 30 minutes at room temperature. Then, the products were separated using magnetic separation and ...
9
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... ± 10 g) were obtained from the SPF ...° C–26 ° C) with 45%–70% humidity and a 12/12-hour light/dark ...for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm ...
16
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... A 10 mL blood sample was taken from a New Zealand rabbit (male, ...to 10 mL normal saline). Fe 3 O 4 was washed twice with distilled water, dried, and suspended using normal saline (final ...
10
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... 60%. Fe 3 O 4 @SiO 2 /PEI, Fe 3 O 4 @SiO 2 / PEI/Sc shRNA, or Fe 3 O 4 @SiO 2 /PEI/VEGF shRNA was incubated with the cells in serum-free medium for 6 hours, and then replaced with complete cell ...
13
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... developed Fe 3 O 4 -based poly(lactic-co- glycolic acid) (PLGA) nanoparticles (NPs) surface-modified with a cyclic Arg-Gly-Asp (cRGD) peptide as an MR contrast agent for the detection of ...The Fe 3 O 4 ...
14
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... average weights of the three TiO 2 NP groups and three Fe 3 O 4 - TiO 2 NP groups were 399.16 ± 13.56 g, 401.50 ± 16.48 g, 409.80 ± 26.60 g, 427.83 ± 23.16 g, 396.71 ± 27.86 g, and 413.80 ± 25.74 g, respectively. ...
15
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... time, the peak values were 119 ± 9 µ g/g and 211 ± 18 µ g/g, respectively, on day 3 after dosing. The value in the lung was 131 ± 15 µ g/g at six hours after dosing, and then decreased steadily. Levels in both kidneys ...
6
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... ° C ± ...° C). Under this condition, the effect of various incubation times (10–45 minutes) on the immunosensor current was investigated at 1 mg/mL of ...
11
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... of Fe 3 O 4 ...experimental Fe 3 O 4 -MNPs/DNR groups and negative controls (P ...the Fe 3 O 4 -MNPs/DNR was ...experimental Fe 3 O 4 -MNPs/ DNR groups were ...Self-assembled Fe 3 O 4 ...
6
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... Reagents used in cell culture include albumin solution from bovine serum (Sigma-Aldrich Co.), ascorbic acid (C 6 H 8 O 6 ; Sigma-Aldrich Co.), Dulbecco’s Modified Eagle’s Medium (DMEM; high glucose with l ...
12
Combination of PEI-Mn<sub>0.5</sub>Zn<sub>0.5</sub>Fe<sub>2</sub>O<sub>4</sub> nanoparticles and pHsp 70-<em>HSV</em>-<em>TK</em>/GCV with magnet-induced heating for treatment of hepatoma
... issues raise the question of how to effectively control the expression of exogenous genes in vivo, at a level that mimics their natural temporal and spatial expression. Such questions must be answered prior to embarking ...
15
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... nanoprobe Fe 3 O 4 @SiO 2 modified with anti-mesothelin antibody (A-MFS) was prepared to target cells and tumor tissues highly expressing mesothelin in vitro (human pancreatic cancer cell line SW1990) and in vivo ...
13
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... ° C, and then diluted as needed in RPMI 1640 medium (Gibco/BRL, Carlsbad, ...containing 10% (v/v) heat-inactivated new-born calf serum (Sijiqing, Hangzhou, China) by using ultrasound treatment in order to ...
9
Synthesis, Characterization and Gas Sensing Performance of PbMnO<sub>3</sub>, PbMnO<sub>3 </sub>: SiO<sub>2</sub> and PbMnO<sub>3 </sub>: Al<sub>2</sub>O<sub>3</sub>
... gas concentration at an operating temperature 50°C and is presented in Fig. 7a–c. It is observed that the sensitivity increases substantially in all three sensors prepared. In case of these three catalysts ...
10
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... Recently, nanometer-sized magnetic particles have been intensively investigated due to their particularly large surface:volume ratio, quantum-size effect, magnetic character as well as their potential application in the ...
6
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... with Fe 3 O 4 -MNP increased to 41.71 ° C ± 1.52 ° C and in those treated with Fe 3 O 4 -MNP- DNR-5-BrTet the temperature increased to ...° C ± 1.8 ° C after 20 minutes of ...
9
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... g/mL, 10 µ g/mL, or 100 µ g/mL) for 24 hours in the absence or presence of N-acetylcysteine (NAC; 10 mM) (Sigma-Aldrich Co); NAC was added 3 hours before treatment with MgNPs-Fe 3 O 4 ...
10